S&P Futures
4,373.25 +12.25 (+0.28%) Dow Futures
34,303.00 +71.00 (+0.21%) Nasdaq Futures
14,921.25 +51.75 (+0.35%) Russell 2000 Futures
1,798.80 +6.10 (+0.34%) Crude Oil
90.54 +0.51 (+0.57%) Gold
1,946.40 +0.80 (+0.04%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 12.57 |
| Open | 12.56 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 12.43 - 12.65 |
| 52 Week Range | 11.30 - 19.77 |
| Volume | |
| Avg. Volume | 840,906 |
| Market Cap | 1.379B |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | 14.85 |
| EPS (TTM) | 0.85 |
| Earnings Date | Sep 25, 2023 - Oct 05, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Oct 07, 2008 |
| 1y Target Est | 17.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MDRX
Related Research
- Veradigm Inc.Analyst Report: Veradigm IncVeradigm, formerly Allscripts Healthcare Solutions, is a provider of electronic health record solutions for physicians, group practices, ambulatory facilities, and hospitals. The company also provides practice management systems, clinical software, and connectivity solutions for physicians. The company has approximately 8,000 employees.RatingFair ValueEconomic Moat3 days agoArgus Research
Business WireVeradigm Inc. Announces Receipt of Nasdaq Delisting Notice and Intent to Appeal
CHICAGO, September 22, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that, on September 20, 2023 and as anticipated in its September 18 release, it received a notice from Nasdaq indicating that the Company’s shares would be delisted due to noncompliance with Nasdaq Listing Rule 5250(c)(1), because the Company did not file its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the "Q1 Form 10-
Business WireVeradigm Inc. Provides Audit Update and Updates Financial Guidance for 2023
CHICAGO, September 18, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that the work effort to conclude on its previously disclosed accounting and internal control errors has taken longer than previously expected, and more time is needed to complete its audit procedures. As such, today the Company will not be filing its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), or its Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2023, and June 30, 2
GlobeNewswireMelissa Supports Healthcare Practice Management Providers with Project US@ Data Compliance
Federal guidelines embrace importance of patient addresses for health IT developers powering analytics, patient matching, and overall careRANCHO SANTA MARGARITA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Melissa, a leading provider of global data quality, identity verification, and address management solutions, today announced its support of healthcare practice management providers in meeting compliance with Project US@, a federal data initiative to create a unified, industrywide specification f
